ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Montana » Neurology

Top Neurology Prescribers in Montana

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
BRET LINDSAY MD

Neurology

3,030

$1M

261
142 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

6%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 27%

$331
Average prescription price

Avg: $341

ELIAD CULCEA MD

Neurology

2,692

$726K

270
150 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 27%

$270
Average prescription price

Avg: $341

ARTURO ECHEVERRI M.D.

Neurology

2,675

$735K

332
220 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 27%

$275
Average prescription price

Avg: $341

ANTHONY WILLIAMSON M.D.

Neurology

2,289

$320K

180
114 are 65+

23%
patients receiving schedule two controlled substances

Avg: 3%

18%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 27%

$140
Average prescription price

Avg: $341

SHERRY REID MD

Neurology

1,973

$971K

203
112 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

7%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 27%

$492
Average prescription price

Avg: $341

DENNIS DIETRICH MD

Neurology

1,948

$1.46M

142
81 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 27%

$751
Average prescription price

Avg: $341

STUART KIERAN MD

Neurology

1,896

$693K

160
89 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 27%

$365
Average prescription price

Avg: $341

THOMAS MULGREW MD

Neurology

1,740

$389K

139
52 are 65+

27%
patients receiving schedule two controlled substances

Avg: 3%

9%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 27%

$224
Average prescription price

Avg: $341

CARLOS SULLIVAN MD

Neurology

1,734

$720K

120
52 are 65+

24%
patients receiving schedule two controlled substances

Avg: 3%

21%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 27%

$415
Average prescription price

Avg: $341

LENNARD WILSON M.D.

Neurology

1,727

$418K

161
98 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 27%

$242
Average prescription price

Avg: $341

JOHN SCHAEFFER D.O

Neurology

1,647

$519K

198
124 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 27%

$315
Average prescription price

Avg: $341

JOSHUA KNAPPENBERGER M.D.

Neurology

1,595

$864K

145
88 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 27%

$542
Average prescription price

Avg: $341

DENNIS OBRIEN MD

Neurology

1,510

$763K

167
95 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 27%

$505
Average prescription price

Avg: $341

DONALD STONE MD

Neurology

1,495

$434K

151
100 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 27%

$290
Average prescription price

Avg: $341

LOWELL QUENEMOEN M.D.

Neurology

1,440

$180K

207
113 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

11%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 27%

$125
Average prescription price

Avg: $341

DEBORAH DOVER MD

Neurology

1,215

$475K

110
52 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 27%

$391
Average prescription price

Avg: $341

RICHARD POPWELL M.D.

Neurology

1,111

$358K

130
93 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 27%

$323
Average prescription price

Avg: $341

KURT LINDSAY MD

Neurology

902

$101K

147
102 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

9%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 27%

$111
Average prescription price

Avg: $341

THOMAS SWANSON MD

Neurology

893

$337K

87
33 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 27%

$377
Average prescription price

Avg: $341

STEPHEN JOHNSON M.D.

Neurology

862

$321K

84
52 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 27%

$373
Average prescription price

Avg: $341

SCOTT RIGGINS MD

Neurology

742

$194K

119
92 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 27%

$262
Average prescription price

Avg: $341

WILLIAM HENNING DO

Neurology

508

$133K

59
40 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 4%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 27%

$261
Average prescription price

Avg: $341

ROBERT SCHIMPFF MD

Neurology

177

$90.8K

25
15 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 27%

$513
Average prescription price

Avg: $341

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank